Mount Sinai Hospital (Canada)
🇨🇦Canada
Clinical Trials
154
Active:7
Completed:65
Trial Phases
5 Phases
Phase 1:7
Phase 2:19
Phase 3:15
+2 more phases
Drug Approvals
0
Drug Approvals
No drug approvals found
This company may not have drug approvals in our database
Clinical Trials
Distribution across different clinical trial phases (130 trials with phase data)• Click on a phase to view related trials
Not Applicable
79 (60.8%)Phase 2
19 (14.6%)Phase 3
15 (11.5%)Phase 4
10 (7.7%)Phase 1
7 (5.4%)Methoxyflurane for IUD Insertion and Endometrial Biopsy
Not Applicable
Recruiting
- Conditions
- Intrauterine DevicesEndometrial Biopsy
- Interventions
- Other: Placebo Penthrox inhaler
- First Posted Date
- 2025-07-01
- Last Posted Date
- 2025-07-01
- Lead Sponsor
- Mount Sinai Hospital, Canada
- Target Recruit Count
- 174
- Registration Number
- NCT07046572
- Locations
- 🇨🇦
OPG, Toronto, Ontario, Canada
Fetoscopic Robotic Open Spina Bifida Treatment
Not Applicable
Not yet recruiting
- Conditions
- Fetal Congenital AbnormalitiesFetoscopyFetal SurgeryRobotic Surgical ProcedureNeural Tube DefectOpen Spina Bifida
- First Posted Date
- 2025-04-02
- Last Posted Date
- 2025-05-07
- Lead Sponsor
- Mount Sinai Hospital, Canada
- Target Recruit Count
- 15
- Registration Number
- NCT06907732
Evaluating the Use of Educational Videos in Newly Diagnosed Patients in a Medical Oncology Sarcoma Clinic
Not Applicable
Not yet recruiting
- Conditions
- Sarcoma
- First Posted Date
- 2025-02-03
- Last Posted Date
- 2025-02-03
- Lead Sponsor
- Mount Sinai Hospital, Canada
- Target Recruit Count
- 100
- Registration Number
- NCT06805773
- Locations
- 🇨🇦
Mount Sinai Hospital, Toronto, Ontario, Canada
This is a Randomized Study of Early Involvement of Palliative Care Along Side Standard Treatment Versus Standard Treatment Alone in Newly Diagnosed Patients With Advanced or Metastatic Soft Tissue Sarcoma (SARQUALITY)
Not Applicable
Recruiting
- Conditions
- Sarcoma
- First Posted Date
- 2025-02-03
- Last Posted Date
- 2025-02-03
- Lead Sponsor
- Mount Sinai Hospital, Canada
- Target Recruit Count
- 136
- Registration Number
- NCT06805669
- Locations
- 🇨🇦
Mount Sinai Hospital, Toronto, Ontario, Canada
Antiviral Strategies in the Prevention of Long-term Cardiovascular Outcomes Following COVID-19: The paxloviD/Remdesivir Effectiveness For the prEvention of loNg coviD Clinical Trial
Phase 4
Recruiting
- Conditions
- SARS CoV-2 Post-Acute Sequelae
- Interventions
- First Posted Date
- 2025-01-24
- Last Posted Date
- 2025-01-24
- Lead Sponsor
- Mount Sinai Hospital, Canada
- Target Recruit Count
- 118
- Registration Number
- NCT06792214
- Locations
- 🇨🇦
Kingston Health Sciences Centre, Kingston, Ontario, Canada
🇨🇦Niagara Health System, St. Catharines, Ontario, Canada
🇨🇦Mount Sinai Hospital, Sinai Health System, Toronto, Ontario, Canada
- Prev
- 1
- 2
- 3
- 4
- 5
- 31
- Next
News
No news found